CEVR analyzes the value of strategies to improve health and health care.

About Us

News & Events

The Best Books I Read in 2024

The Best Books I Read in 2024 Peter J. Neumann Earlier this year, the New York Times released its 100 best books of the 21st Century, and I discovered...

Read more December 10, 2024
Call for Papers: 2024 Tufts-CEVR Cost-Effectiveness Analysis Paper of the Year

Call for Papers! 2024 Tufts-CEVR Cost-Effectiveness Analysis Paper of the Year The Center for the Evaluation of Value and Risk in Health (CEVR) at T...

Read more November 11, 2024
Join our team: CEVR is hiring an HEOR Researcher

Job Overview The Senior Research Associate will work on projects within the Center for the Evaluation of Value and Risk in Health (CEVR), performing ...

Read more November 15, 2024
View All News & Events

Recent Publications

STAT
Medicare’s new transitional coverage of emerging technologies program doesn’t go far enough
View publication
August 28, 2024
Value in Health
The health benefits, costs, and cost-effectiveness of ultraorphan drugs
View publication
July 31, 2024
Health Affairs Forefront
Improving how CMS defines “unmet medical need” under the IRA
View publication
July 30, 2024
Archives of Dermatological Research
Impact on quality of life, health care access, and health care utilization of individuals with vitiligo: an analysis of the All of Us Research Program
View publication
November 26, 2024
JAMA Network Open
Modeling the population equity of Alzheimer Disease treatments in the US
View publication
October 31, 2024
BMJ Global Health
Disparities in availability of new cancer drugs worldwide: 1990-2022
View publication
October 8, 2024
Alzheimer's & Dementia
Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease
View publication
October 6, 2024
Alzheimer's & Dementia
Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's disease
View publication
October 1, 2024
Health Affairs Scholar
Public deliberation on health gain measures
View publication
September 9, 2024
Health Affairs
US commercial plans increase choice of biosimilar and originator products; market net prices decrease
View publication
September 4, 2024
View All Publications

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.

CEA Registry

The CEA Registry is a comprehensive database of 9,080 cost-utility analyses on a wide variety of diseases and treatments.

View Registry

Global Health CEA Registry

The GH CEA Registry is the first comprehensive database to compile articles utilizing the “cost-per-DALY averted” metric to measure the efficacy of health interventions.

View Registry

SPEC Database

The Specialty Drug Evidence and Coverage (SPEC) Database is a new data resource developed with the goal of providing an empirical basis to commercial payer specialty drug coverage.

View Database
Learn About Our Databases